{"lastClose": 5.099999904632568, "len": 970, "date": "2023-02-08", "alpha_1": -0.7483771110417694, "beta_1": 0.9220193701304192, "drawup_1": 0.7155424508464454, "natr_1": 17.17391550724954, "sup_1": -0.9849672875678733, "res_1": 0.624183030674187, "bullPattern_1": [], "bearPattern_1": ["HARAMI"], "rsi_1": 49.5327106968619, "adx_1": 28.852564036237936, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.5815918561017422, "stratHoldAlpha_1": 250.51591385375193, "stratHoldDrawdown_1": -0.731532145026727, "alpha_3mo": -0.29130716283141855, "beta_3mo": 1.514995623572724, "drawup_3mo": 0.20805376931257258, "natr_3mo": 17.17391550724954, "sup_3mo": -0.08732026082681395, "res_3mo": 0.011241825787696764, "bullPattern_3mo": [], "bearPattern_3mo": ["CLOSINGMARUBOZU", "LONGLINE"], "rsi_3mo": 53.38345029002846, "adx_3mo": 71.03259635388251, "drawdown_3mo": -0.2358974593056159, "stratHoldSharpe_3mo": -0.7131801584922204, "stratHoldAlpha_3mo": 250.6336933711473, "stratHoldDrawdown_3mo": -0.2124529802339168, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "NGM Biopharmaceuticals Inc.", "IPO Year": 2019.0, "Sector": "Health Care", "Market Cap": 419254960, "alpha%_1": 0.017962916154561557, "beta%_1": 0.44848562591396646, "drawup%_1": 0.6698752684041723, "natr%_1": 0.9999999893510101, "drawdown%_1": 0.017986819888732453, "stratHoldSharpe%_1": 0.15436876999928834, "stratHoldAlpha%_1": 0.018891898262878726, "stratHoldDrawdown%_1": 0.019766991180619583, "alpha%_3mo": 0.1888536161969444, "beta%_3mo": 0.8126941343012541, "drawup%_3mo": 0.38955668159560847, "natr%_3mo": 0.9999999817120517, "drawdown%_3mo": 0.17402716839921323, "stratHoldSharpe%_3mo": 0.15392843494458214, "stratHoldAlpha%_3mo": 0.11022939461858172, "stratHoldDrawdown%_3mo": 0.17857994739289196}